# 3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals

> **NCT01721265** · — · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 145 (actual)

## Conditions studied

- Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01721265
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2015-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01721265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01721265, "3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT01721265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*